Empowering Progressive Medical Affairs Executives
Our priorities are your priorities—our member-driven research initiatives fuel reports, presentations, and decision guides to help you: (1) understand how customers make decisions, (2) optimize sources and uses of medical evidence, and (3) drive more productive conversations around value.

Learn About Membership


Our value story

Download our research briefing to learn more about the top 10 issues that warrant further research, helping to shape our research agenda.

Life sciences executives are faced with a difficult challenge—they have to clearly articulate product value in ways that resonate with different customers. Oftentimes, they are operating at the intersection of clinical research and customer engagement, and are working on competing timelines and value frameworks.

We spoke with 75 medical leaders across pharmaceutical, medical device, and diagnostic firms to discuss their most pressing issues—and over 50 themes and priorities surfaced.

Membership Features

Member-Driven Research

Solicit your input on what topics to prioritize each year and get feedback on research approach and questions

Dedicated Service Advisor

Engage regularly with you to support dissemination of key learnings, and hear what you want for future research

Expert Commentaries

Distill signal from noise, with attention to salient implications of major trends and news (e.g., primers, market scans, policy briefs)

Intimate Cohort Roundtables

Foster action-oriented conversations with experts and peers grounded in our latest research findings

Cross-Industry Summits

Convene payer, provider, pharmacy, and life science leaders for honest dialogues about value and partnership

Virtual Roundtables

Receive our latest research findings and meaningful discussion between medical affairs leaders across the country

Meet our experts

“One of the things I’ve always admired about Advisory Board is the story behind the data. You understand it, but you’re not part of it. That kind of stuff speaks to health care professionals. The advantage I see for Advisory Board is that you’re also not trying to do medical affairs. You are trying to make medical affairs better.”

—VP, Medical Affairs, large pharmaceutical firm

Each year, our research experts are invited to speak at industry conferences across the country. At Eyeforpharma 2020, we provided an inside look into what your customers think about real-world evidence. In case you missed it, our 15-minute presentation, “How to change how we talk about RWE and who accepts it,” is available on-demand.

At Eyeforpharma 2019, we delivered a standing-room only presentation, “How Payers and IDNs Think About Value and the Data They Trust to Make Decisions.” Download the presentation to get a glimpse into the kind of research our team produces about value. Fill out the form to connect with our experts and learn more.

What to check out next

Daily Briefing

ICER 101

How the 'drug pricing watchdog' is changing how we perceive value
Read now

Cross-Industry Value Summit

Exclusive Invite-Only Event

We convened 40 medical and pharmacy leaders from across the health care ecosystem.
See what happened.